RSV(Respiratory Syncytial Virus)

🦠 Viral Seasonality & The Rising Concern of RSV

**Post-COVID**, viral seasonality has become **less predictable**, with **continuous surges** in **respiratory viral infections** over the last **2-3 years**.

**Current data** from **India and globally** suggests that **no new virus is posing a major threat**. However, **Respiratory Syncytial Virus (RSV)** has gained **significant attention** due to rising hospitalization rates.

💨 RSV - A Common Yet Emerging Threat

**RSV (Respiratory Syncytial Virus)** is typically a **mild winter virus**, causing **cold-like symptoms**.

**Unlike COVID-19 or Influenza**, RSV usually does **not** lead to severe **morbidity or mortality** in adults, but it **can cause bronchiolitis in children**.

**Recent trends, however, indicate:**

  • 📈 **Increased hospitalizations** across all age groups.
  • 🛏️ **Severe cases in adults**, which was uncommon before.
  • 🔬 **Better detection** due to widespread use of multiplex **PCR & triple tests (Xpert).**
Friday ID Day

💊 Treatment Challenges & The Need for Early Diagnosis

**Unlike Influenza**, RSV **does not have regular antiviral treatments**. However, in **severely ill & immunocompromised patients**, the following options are available:

**Early detection is critical** since treatments vary across different **viral pneumonias**.

🛡️ RSV Vaccine - A Future Solution?

**A new RSV vaccine is currently available in the US** and is expected to be **introduced in India soon**.

**Widespread vaccination** could help reduce the impact of RSV, especially in **high-risk groups**.

📢 Key Takeaways

📢 Stay Connected

Get connected with us on social networks!